John Poyhonen, Director at Ardea Biosciences, Inc./DE (RDEA), sold 8,000 shares at $15.00 ($122K) on 2009-05-20, disclosed to the SEC on 2009-05-21.
Open-market sale of $122k RDEA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.34 | 5,000 | $77K | 63.0% |
| 2 | $15.00 | 3,000 | $45K | 37.0% |
| Total | $15.21 avg | 8,000 | $122K | 100% |
| Filing → |
| SNMX | BUY | 2017-03-23 | $49K | — | Filing → |
| HRTX | BUY | 2017-01-23 | $122K | — | Filing → |
| SNMX | SELL | 2014-06-06 | $301K | — | Filing → |